Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Pulmonx | LUNG | Nov 27, 2024 | 6.30 | -2.48 |
Pulse Biosciences | PLSE | Nov 27, 2024 | 20.37 | +0.34 |
PulteGroup | PHM | Nov 27, 2024 | 136.53 | +0.69 |
Puma Biotechnology | PBYI | Nov 27, 2024 | 3.23 | +2.87 |
Pure Cycle | PCYO | Nov 27, 2024 | 14.45 | +0.21 |
Pure Storage A | PSTG | Nov 27, 2024 | 52.89 | -3.13 |
PureCycle Technologies | PCT | Nov 27, 2024 | 13.20 | -0.60 |
PureCycle Technologies Unit | PCTTU | Nov 27, 2024 | 15.88 | +13.43 |
Purefunds ISE Junior Silver [Sm | SILJ | Nov 27, 2024 | 11.79 | +0.60 |
PureTech Health ADR | PRTC | Nov 27, 2024 | 23.39 | +10.12 |
Purple Biotech ADR | PPBT | Nov 27, 2024 | 3.25 | +23.11 |
Purple Innovation | PRPL | Nov 27, 2024 | 0.96 | +4.61 |
Putnam Managed Municipal Income Trust | PMM | Nov 27, 2024 | 6.36 | +2.42 |
Putnam Master Intermediate Income Trust | PIM | Nov 27, 2024 | 3.23 | +0.31 |
Putnam Municipal Opportunities Trust | PMO | Nov 27, 2024 | 10.63 | +1.92 |
Putnam Premier Income Trust | PPT | Nov 27, 2024 | 3.52 | -0.42 |
PVH | PVH | Nov 27, 2024 | 106.88 | -0.62 |
Pyrophyte Acquisition | PHYT | Nov 27, 2024 | 11.55 | 0.00 |
Pyxis Oncology | PYXS | Nov 27, 2024 | 1.83 | +3.39 |
Pyxis Tankers | PXS | Nov 27, 2024 | 3.81 | -1.80 |
Pyxis Tankers Pref | PXSAP | Nov 27, 2024 | 24.97 | 0.00 |
Q2 | QTWO | Nov 27, 2024 | 104.49 | -2.34 |
Q32 Bio | QTTB | Nov 27, 2024 | 26.92 | +7.29 |
QCR | QCRH | Nov 27, 2024 | 93.51 | -0.35 |
QIAGEN | QGEN | Nov 27, 2024 | 43.75 | +1.18 |
Qifu Technology ADR | QFIN | Nov 27, 2024 | 37.88 | +6.17 |
QMMM | QMMM | Nov 27, 2024 | 1.26 | +26.00 |
Qomolangma Acquisition | QOMO | Nov 27, 2024 | 11.55 | 0.00 |
Qorvo | QRVO | Nov 27, 2024 | 68.40 | +0.37 |
QT Imaging | QTI | Nov 27, 2024 | 0.48 | -0.77 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.